-

Thermo Fisher Scientific Launches User-Friendly Raman Spectroscopic Analyzer

Continuous sample monitoring without the technical barriers

TEWKSBURY, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. today announced the release of a new Raman spectroscopic analyzer for process monitoring for a variety of applications, including biopharmaceutical manufacturing. The Thermo Scientific Ramina Process Analyzer offers non-destructive and continuous analysis without the need for sample preparation, with rapid system setup and deployment in as little as 15 minutes to generate spectral data on target analytes within seconds.

This easy-to-use system is designed to eliminate the complexity of performing Raman spectroscopy measurements, making the technique accessible to all levels of user experience while maintaining high precision and accuracy. The compact system utilizes a range of patented probes to maximize the speed and sensitivity of results, enabling fully automated in situ measurements to calculate concentrations in a reaction vessel.

The Ramina Process Analyzer offers a rapid and easy-to-use alternative to offline manual or automated wet chemistry testing, and is simpler to install and use compared to traditional Raman process monitoring systems. Ramina comes with everything the user needs to start collecting data, including a Raman spectrometer and fiber optic probe, as well as a portable monitor, mouse, keyboard and laser safety goggles. Factory calibration ensures the Ramina system is ready to use without delay, and its solid-state construction offers long-term stability, meaning users can enjoy continuous, highly accurate measurements without frequent calibration. Users can also use multiple systems in parallel to test different reaction vessels simultaneously, or combine a number of probes in one vessel.

Chloe Hansen-Toone, vice president and general manager for field and safety instruments at Thermo Fisher, commented: “We are excited to launch the Ramina Process Analyzer, which offers an almost effortless method of performing precise in situ Raman measurements, enabling customers to generate real-time data where and when they need it. The compact and portable design of this analyzer, as well as its user-friendly operation, will help to reduce time-to-results without the burden of taking up too much valuable laboratory space.”

For more information, thermofisher.com/ramina

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:
Name: Becca Quine
kdm communications limited
Phone: +44 1480 405 333
E-mail: rebeccaq@kdm-communications.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Summary
Thermo Scientific new product Ramina Process Analyzer enables real time, accurate results for process monitoring.
Release Versions

Contacts

Media Contact Information:
Name: Becca Quine
kdm communications limited
Phone: +44 1480 405 333
E-mail: rebeccaq@kdm-communications.com

More News From Thermo Fisher

Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitment to supporting the region’s rapidly growing biopharmaceutical industry. The company is introducing a new Bioprocess Design Center in Hyderabad, India, and has expanded its existing Bioprocess Design Centers in Incheon, Korea and Singapore, further strengthening a strategic regional network desig...

Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly-owned finance subsidiary: €1,000,000,000 aggregate principal amount of its floating rate senior notes due 2027 (the “floating rate notes”) at the issue price of 100.000%...

Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic (CDx) to identify patients who may be eligible for treatment with HYRNUO™ (sevabertinib), a new HER2-directed therapy developed and commercialized by Bayer. The test enables clinicians and pathologists to identify non-small cell lung cancer (NSCLC) tumors wi...
Back to Newsroom